MedPath

Observational Study of Vision Improvement in Patients With Retinal Disorders

Completed
Conditions
Age-related Macular Degeneration
Diabetic Macular Edema
Interventions
Device: Corneal treatment by a low vision aid device
Registration Number
NCT04693702
Lead Sponsor
Optimal Acuity Corporation
Brief Summary

The purpose of this study is to assess the vision improvement achieved by patients with retinal disorders who received corneal treatments by a low vision aid device.

Detailed Description

The purpose of this study is to assess the vision improvement achieved by patients with retinal disorders, including age-related macular degeneration and diabetic macular edema, who received corneal treatments by a low vision aid device. Patient records will be analyzed to determine measures of vision improvement including best spectacle-corrected distance visual acuity (CDVA). Analyses will include descriptive statistics and correlation between outcomes and baseline characteristics.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
54
Inclusion Criteria
    • Female or male
    • Any race
    • Patient is at least 50 years old
    • Patient has diagnosed retinal disorder that causes central vision loss in one or both eyes
    • Treated eyes, at time of treatment, were pseudophakic or phakic with no significant vision loss due to cataract
    • Patient had moderate to severe baseline vision impairment with CDVA of 20/63 or worse (decimal = 0.317 or less; logMAR greater than or equal to 0.50) in the treated eye(s)
    • Patient CDVA records are available at baseline and at 1m or longer post-Tx times
Exclusion Criteria

1 - Corneal disease or disorder in either eye 2 - Increased intraocular pressure (above 20mm Hg), glaucoma or history of glaucoma 3 - Presence or history of any other condition or finding that, in the opinion of the investigator, makes the patient unsuitable for retrospective observational study

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Age-related Macular DegenerationCorneal treatment by a low vision aid device-
Diabetic Macular EdemaCorneal treatment by a low vision aid device-
Primary Outcome Measures
NameTimeMethod
CDVA12 months

Best spectacle-corrected distance visual acuity

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Bochner Eye Institute

🇨🇦

Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath